Mesurer le risque perçu à « jouer responsable » = MEASURING THE PERCEIVED RISK OF GAMBLING RESPONSIBLYPIN, Anne-Claire; PICOT-COUPEY, Karine; DROULERS, Olivier et al.Journal de gestion et d'économie médicales. 2014, Vol 32, Num 3, pp 227-239, issn 2262-5305, 13 p.Article

A Review of the Economics of Treating Clostridium difficile InfectionMERGENHAGEN, Kari A; WOJCIECHOWSKI, Amy L; PALADINO, Joseph A et al.PharmacoEconomics (Auckland). 2014, Vol 32, Num 7, pp 639-650, issn 1170-7690, 12 p.Article

Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income Countries Useful? Examples from the World of VaccinesNEWALL, A. T; JIT, M; HUTUBESSY, R et al.PharmacoEconomics (Auckland). 2014, Vol 32, Num 6, pp 525-531, issn 1170-7690, 7 p.Article

Challenges in Modelling the Cost Effectiveness of Various Interventions for Cardiovascular DiseaseBURGERS, Laura T; REDEKOP, William K; SEVERENS, Johan L et al.PharmacoEconomics (Auckland). 2014, Vol 32, Num 7, pp 627-637, issn 1170-7690, 11 p.Article

Cost-Effectiveness Analysis of Interventions for Tuberculosis Control: DALYs Versus QALYsDIEL, R; LAMPENIUS, N.PharmacoEconomics (Auckland). 2014, Vol 32, Num 7, pp 617-626, issn 1170-7690, 10 p.Article

Do Changes in Drug Coverage Policy Point to an Increased Role for Cost-Effectiveness Analysis in the USA?CHAMBERS, James D.PharmacoEconomics (Auckland). 2014, Vol 32, Num 8, pp 729-733, issn 1170-7690, 5 p.Article

Load-sensitive dynamic workflow re-orchestration and optimisation for faster patient healthcareMELI, Christopher L; KHALIL, Ibrahim; TARI, Zahir et al.Computer methods and programs in biomedicine (Print). 2014, Vol 113, Num 1, pp 1-14, issn 0169-2607, 14 p.Article

On capacity allocation for operating roomsSANGDO CHOI; WILHELM, Wilbert E.Computers & operations research. 2014, Vol 44, pp 174-184, issn 0305-0548, 11 p.Article

Patient scheduling with periodic deteriorating maintenance on single medical deviceYIFAN WU; MING DONG; ZHENNAN ZHENG et al.Computers & operations research. 2014, Vol 49, pp 107-116, issn 0305-0548, 10 p.Article

Pharmacoeconomic Evaluation of Dabigatran, Rivaroxaban and Apixaban versus Enoxaparin for the Prevention of Venous Thromboembolism After Total Hip or Knee Replacement in SpainGOMEZ-OUTES, Antonio; AVENDANO-SOLA, Cristina; TERLEIRA-FERNANDEZ, Ana Isabel et al.PharmacoEconomics (Auckland). 2014, Vol 32, Num 9, pp 919-936, issn 1170-7690, 18 p.Article

Review of Models Used in Economic Analyses of New Oral Treatments for Type 2 Diabetes MellitusASCHE, Carl V; HIPPLER, Stephen E; EURICH, Dean T et al.PharmacoEconomics (Auckland). 2014, Vol 32, Num 1, pp 15-27, issn 1170-7690, 13 p.Article

Simulations and fuzzy systems for resource reallocation : Modeling Sustainability for the 3rd MillenniumMUNOZ, V; CALLERO, Y; AGUILAR, R. M et al.Simulation (San Diego, Calif.). 2014, Vol 90, Num 2, pp 205-215, issn 0037-5497, 11 p.Article

Survival Modeling for the Estimation of Transition Probabilities in Model-Based Economic Evaluations in the Absence of Individual Patient Data: A TutorialDIABY, Vakaramoko; ADUNLIN, Georges; MONTERO, Alberto J et al.PharmacoEconomics (Auckland). 2014, Vol 32, Num 2, pp 101-108, issn 1170-7690, 8 p.Article

The Impact of Structural Uncertainty on Cost-Effectiveness Models for Adjuvant Endocrine Breast Cancer Treatments: the Need for Disease-Specific Model Standardization and Improved GuidanceFREDERIX, Gerardus W. J; VAN HASSELT, Johan G. C; SCHELLENS, Jan H. M et al.PharmacoEconomics (Auckland). 2014, Vol 32, Num 1, pp 47-61, issn 1170-7690, 15 p.Article

Use of Proton Pump Inhibitors for the Provision of Stress Ulcer Prophylaxis: Clinical and Economic ConsequencesBARLETTA, Jeffrey F; SCLAR, David A.PharmacoEconomics (Auckland). 2014, Vol 32, Num 1, pp 5-13, issn 1170-7690, 9 p.Article

Rituximab in Combination with Corticosteroids for the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A NICE Single Technology AppraisalLATIMER, Nicholas R; CARROLL, Christopher; RUTH WONG et al.PharmacoEconomics (Auckland). 2014, Vol 32, Num 12, pp 1171-1183, issn 1170-7690, 13 p.Article

Adaptation dynamique de processus métier: Application au circuit du médicament à l'AP-HMANGLES, Renaud; RAMADOUR, Philippe; CAUVET, Corine et al.Ingénierie des systèmes d'information (2001). 2014, Vol 19, Num 2, pp 35-60, issn 1633-1311, 26 p.Article

Une organisation d'action sociale et médico-sociale face aux injonctions des pouvoirs publics: le cas de l'ACSEA de 1982 à 2010. Une approche par l'étude des règles = A NON-PROFIT ORGANIZATION IN THE SOCIAL-MEDICAL SECTOR FACING PUBLIC INJUNCTIONS - THE CASE OF ACSEA: 1982-2010. AN APPROACH BY THE STUDY OF RULESJOFFRE, Clémence.Journal de gestion et d'économie médicales. 2014, Vol 32, Num 1, pp 46-62, issn 2262-5305, 17 p.Article

Les premières années des ARS dans le secteur médico-social = REGIONAL HEALTH AGENCIES AND SOCIAL CARE: THE FIRST YEARSHUDEBINE, Hervé; JOURDAIN, Alain; MUNOZ, Jorge et al.Journal de gestion et d'économie médicales. 2014, Vol 32, Num 1, pp 81-96, issn 2262-5305, 16 p.Article

Successful Implementation of eRx Systems: Creating Technology―Organization Alignment using the Strategy-Map ApproachNAN XIAO; MAHAJAN, Supriya; KISHORE, Rajiv et al.Information systems management. 2014, Vol 31, Num 1-2, pp 104-119, issn 1058-0530, 16 p.Article

A Choice That Matters?: Simulation Study on the Impact of Direct Meta-Analysis Methods on Health Economic OutcomesVEMER, Pepijn; AL, Maiwenn J; OPPE, Mark et al.PharmacoEconomics (Auckland). 2013, Vol 31, Num 8, pp 719-730, issn 1170-7690, 12 p.Article

Economic impact of ambulatory care formulary restrictions at a large county health systemCENTENO, Alexandra; PRICE, Venessa; ROBINSON, Natasha et al.American journal of health-system pharmacy. 2013, Vol 70, Num 14, pp 1238-1243, issn 1079-2082, 6 p.Article

Formulary systems and pharmacy and therapeutics committees in the Western Pacific Region: Exploring two Basel StatementsPENM, Jonathan; CHAAR, Betty; DECHUN, Jiang et al.American journal of health-system pharmacy. 2013, Vol 70, Num 11, pp 967-979, issn 1079-2082, 13 p.Article

Length of stay prediction for clinical treatment process using temporal similarityZHENGXING HUANG; JUAREZ, Jose M; HUILONG DUAN et al.Expert systems with applications. 2013, Vol 40, Num 16, pp 6330-6339, issn 0957-4174, 10 p.Article

La tarification à l'activité en SSR: impasse ou opportunité de réforme ? = Prospective payment system in post-acute care: Impasse or opportunity for reform?DEVAILLY, J.-P; JOSSE, L.Journal de réadaptation médicale. 2013, Vol 33, Num 3, pp 96-107, issn 0242-648X, 12 p.Article